PGEN – precigen, inc. (US:NASDAQ)
Stock Stats
News
3/5
08:48 am
pgen
Medium
Precigen (PGEN) Surged Following the Early Approval of Papziemos [Yahoo! Finance]
2/11
09:40 am
pgen
Medium
Precigen: PAPZIMEOS Is Delivering For This Under-The-Radar Biotech [Seeking Alpha]
1/24
06:29 am
pgen
Low
Precigen (NASDAQ:PGEN) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
1/20
08:05 am
pgen
Low
New Expert Consensus Published in The Laryngoscope Recommends PAPZIMEOS (zopapogene imadenovec) as the New Standard of Care First-Line Treatment for Adults with Recurrent Respiratory Papillomatosis
1/12
08:00 am
pgen
Medium
Precigen Showcases Rapid Commercialization Momentum and Growing Market Adoption of First-and-Only FDA-Approved Therapy for RRP at the 44th Annual J.P. Morgan Healthcare Conference
11/13/2025
04:05 pm
pgen
25.6%
MISS
8/12/2025
04:29 pm
pgen
-1.3%
BEAT
5/14/2025
04:05 pm
pgen
2.3%
MISS
2/13
10:57 am
pgen
Low
Form SCHEDULE 13G/A PRECIGEN, INC. Filed by: Patient Capital Management, LLC
1/23
04:06 pm
pgen
Low
Form SCHEDULE 13G PRECIGEN, INC. Filed by: Point72 Asset Management, L.P.
12/22
08:48 pm
pgen
Medium
Form 4 PRECIGEN, INC. For: Dec 22 Filed by: KIRK RANDAL J
12/22
08:19 pm
pgen
Medium
Form 144 PRECIGEN, INC. Filed by: KIRK RANDAL J
12/16
04:17 pm
pgen
Medium
Form 4 PRECIGEN, INC. For: Dec 12 Filed by: KINDLER JEFFREY B
Show more
Top News Gainers
3/23 Form 4 PRECIGEN, INC. For: Mar 23 Filed by: Sterling Rick L. 31.6%
4/20 Precigen Announces Clearance of IND to Initiate Phase I/II Study for First-in-Class PRGN-2009 AdenoVerse™ Immunotherapy to Treat HPV-positive (HPV+) Solid Tumors 20.3%
3/17 Form 4 PRECIGEN, INC. For: Mar 13 Filed by: ALVAREZ CESAR L 11.6%
3/3 Form 4 PRECIGEN, INC. For: Feb 28 Filed by: KIRK RANDAL J 8.4%
4/29 Form DEFA14A PRECIGEN, INC. 5.7%
3/1 Precigen Q4 Earnings Preview [Seeking Alpha] 3.2%
4/2 Form 4 PRECIGEN, INC. For: Mar 31 Filed by: Lehr Donald P. 2.9%
2/11 Form D PRECIGEN, INC. 1.0%
Top News Decliners
3/20 Form 4 PRECIGEN, INC. For: Mar 19 Filed by: KIRK RANDAL J -22.7%
3/2 Q4/2019 12/31/2019 EPS -0.470 ZacksConsensus -0.250 ActVsEst (0.220) - Miss -17.1%
3/10 Form 4 PRECIGEN, INC. For: Mar 08 Filed by: Turley James S -7.6%
3/17 Precigen (NASDAQ: PGEN) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -5.8%
2/24 Precigen to Announce Fourth Quarter and Full Year 2019 Financial Results on March 2nd -4.6%
2/6 Form 8-K/A PRECIGEN, INC. For: Jan 31 -2.4%
4/2 Form 4 PRECIGEN, INC. For: Mar 31 Filed by: KIRK RANDAL J -2.4%
4/30 Precigen, Inc. (NASDAQ: PGEN) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -1.4%
2/14 Form SC 13G PRECIGEN, INC. Filed by: MILLER VALUE PARTNERS, LLC -0.1%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3